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Amyotrophic lateral sclerosis (ALS) is a progressive para-
lytic disorder that primarily affects motoneurons of the motor
cortex, brainstem and spinal cord. ALS, which is largely
sporadic, typically manifests in midlife, and death follows
3–5 years after onset. The disorder is characterized by
muscle weakness that inexorably evolves into a generalized
paralysis. Unfortunately a cure is not yet available (Mein-
inger 2005; Van Damme and Robberecht 2009).
As the discovery of mutations in the superoxide dismu-
tase-1 (SOD1) gene in familial cases (FALS), an increasing
number of genes in which mutations cause FALS have been
identiﬁed (Dion et al. 2009). From this genetic knowledge,
experimental models that recapitulate the selective vulnera-
bility of motoneurons have been successfully developed in
mice and rats with SOD1 mutants (Turner and Talbot 2008).
Recently mice expressing a TDP-43 mutant with some
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Abstract
A dominant mutation in the gene coding for the vesicle-
associated membrane protein-associated protein B (VAPB)
was associated with amyotrophic lateral sclerosis, a fatal
paralytic disorder characterized by the selective loss of
motoneurons in the brain and spinal cord. Adeno-associated
viral vectors that we show to transduce up to 90% of moto-
neurons in vitro were used to model VAPB-associated neu-
rodegenerative process. We observed that Adeno-associated
viral-mediated over-expression of both wild-type and mutated
form of human VAPB selectively induces death of primary
motoneurons, albeit with different kinetics. We provide evi-
dence that ER stress and impaired homeostatic regulation of
calcium (Ca2+) are implicated in the death process. Finally, we
found that completion of the motoneuron death program trig-
gered by the over-expression of wild-type and mutant VAPB
implicates calpains, caspase 12 and 3. Our viral-based in vitro
model, which recapitulates the selective vulnerability of
motoneurons to the presence of mutant VAPB and also to
VAPB gene dosage effect, identifies aberrant Ca2+ signals
and ER-derived death pathways as important events in the
motoneuron degenerative process.
Keywords: adeno-associated virus, amyotrophic lateral
sclerosis, calcium, endoplasmic reticulum stress, motoneuron
culture, vesicle-associated membrane protein-associated
protein B.
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features of ALS and frontotemporal lobar degeneration have
been documented (Wegorzewska et al. 2009). Complemen-
tarily, primary, embryonic or induced pluripotent stem cell-
based motoneuron cultures from SOD1 mutant mice or ALS
patients are being regarded as a solid approach to gain
insights into physio-pathological mechanisms of ALS (Raoul
et al. 2006; Nagai et al. 2007; Dimos et al. 2008).
A dominantly inherited mutation in the gene encoding for
the vesicle-associated membrane protein-associated protein
B (VAPB) has been associated with typical ALS, atypical
ALS and late-onset spinal muscular atrophy (Nishimura
et al. 2004). VAPB is a ubiquitously expressed membrane-
anchored protein that localizes mainly to the endoplasmic
reticulum (ER) and ER-Golgi intermediate vesicles (Soussan
et al. 1999; Lev et al. 2008). VAPB has been proposed to
play a role in coat protein complex I-mediated retrograde
transport of proteins (Soussan et al. 1999), lipid transfer
toward the Golgi (Peretti et al. 2008), and also to regulate ER
structure through interaction with the microtubule network
(Amarilio et al. 2005; Prosser et al. 2008) or to modulate
response to ER stress (Kanekura et al. 2006; Gkogkas et al.
2008; Suzuki et al. 2009). Studies in neuronal and non-
neuronal cell lines showed that the proline 56 to serine
(P56S) VAPB mutant forms dense cytosolic aggregates
continuous with ER structures. These VAPBP56S inclusions
may exert dominant negative effects by recruiting and
insolubilizing the wild-type form of VAPB (Kanekura et al.
2006; Teuling et al. 2007; Suzuki et al. 2009). However, the
impact of mutant VAPB on the functional integrity of
motoneurons remains elusive.
Here, we report that adeno-associated viral (AAV) vector-
mediated expression of both human wild-type and mutant
VAPB selectively triggers death of embryonic motoneurons.
We provide evidence that ER stress and an impaired calcium
(Ca2+) homeostasis participate in the death program initiated
by wild-type or mutant VAPB over-expression. We demon-
strate that the hVAPB-associated degenerative process occurs
in a caspase-dependent manner in cultured motoneurons. We
describe an in vitro model of VAPB-associated selective
degeneration of motoneurons that provides evidence that
Ca2+ signals associated to ER-derived pathways might
contribute to the pathologic loss of motoneurons.
Materials and methods
Expression constructs
Coding sequences of hVAPB (Genbank NM004738) and human
vesicle-associated membrane protein-associated protein A (hVAPA)
(genebank AK315577) were cloned by PCR from 293T cell cDNA
(TA cloning kit, Invitrogen, Carlsbad, CA, USA) using the
following primers: 5¢-AAAGGTGCTCCGCCGCTAAG-3¢ (hVAPB
sense), 5¢-TTCTTTTCCCCCTCAATCAG-3¢ (hVAPB antisense),
5¢-CCGATGGCGTCCGCCTCAGGGGCC-3¢ (hVAPA sense) and
5¢-CTACAAGATGAATTTCCCTAG-3¢ (hVAPA antisense). To
introduce P56S point mutation, site-directed mutagenesis was
performed by PCR (QuickChange Site Directed Mutagenesis Kit,
Stratagene, La Jolla, CA, USA) using pCR2.1-hVAPBWT as
template and the following primer sequence: 5¢-TGTGTGAGGTC-
CAACAGCGGAATCA-3¢ (sense). pUbc-enhanced green ﬂuores-
cent protein (EGFP), pUbc-hVAPBWT, pUbc-hVAPBP56S and
pUbc-hVAPA were generated from the pCCL-cPPT-phosphoglyce-
rokinase (PGK1)-WPRE expression vector (Raoul et al. 2005), in
which PGK1 has been replaced by the human ubiquitin c promoter
(Araki et al. 2004). To construct AAV vectors carrying EGFP,
hVAPBWT, hVAPBP56S, hVAPA cDNA, we ﬁrst replaced the
cytomegalovirus promoter of pAAV-MCS (Stratagene) by the
mouse PGK1 promoter (Raoul et al. 2005), and then cloned
the corresponding cDNA downstream of PGK1 promoter and
b-globin intron. All cDNA inserts were sequenced to ensure the
integrity of the nucleotidic sequences.
AAV6 production and titration by quantitative real-time PCR
Recombinant AAV serotype 6 vectors were produced as previously
described (Towne et al. 2008), by transient co-transfection of
293AAV cell line with AAV-EGFP, AAV-hVAPBWT, AAV-
hVAPBP56S or AAV-hVAPA and the helper plasmid pDF6 (Grimm
et al. 2003). Forty-eight hours later, AAV particles were puriﬁed
from cell lysates on a heparin afﬁnity column using HPLC.
The titration of infectious AAV particles was performed in 293T
cells by quantitative real-time PCR according to the nuclease S1
methods (Rohr et al. 2005), as previously described (Towne et al.
2008). The primers targeting b-globin intron were 5¢-CGTGCCAA-
GAGTGACGTAAG-3¢ (sense) and 5¢-TGGTGCAAAGAGGCAT-
GATA-3¢ (antisense). Albumin that served as internal control was
ampliﬁed using the following primers: 5¢- TGAAACATACGTTCC-
CAAAGAGTTT-3¢ (sense) and 5¢-CTCTCCTTCTCAGAAAGTGT-
GCATAT-3¢ (antisense). The titers of AAV vectors used in the present
study, depending on the viral preparation, vary between 2.1 and
2.9 · 1010 transducing units (TU)/mL for AAV-EGFP; 1.4 and
6.3 · 109 TU/mL for AAV-hVAPBWT; 1.8 and 2.5 · 1010 TU/mL
for AAV-hVAPBP56S; 2 · 109 TU/mL for AAV-hVAPA.
Cell cultures
Motoneurons from E12.5 spinal cord of CD1 (Charles River
Laboratories Inc., Wilmington, MA, USA) or Hb9::GFP (T.M.
Jessell’s laboratory, Columbia University, NY, USA) mice were
isolated as described (Arce et al. 1999) and modiﬁed (Raoul et al.
2002) using iodixanol density gradient centrifugation. Motoneurons
were plated on poly-ornithine/laminin-treated wells in the presence
of a cocktail of neurotrophic factors (0.1 ng/mL glial-derived
neurotrophic factor, 1 ng/mL brain-derived neurotrophic factor,
and 10 ng/mL ciliary neurotrophic factor) in supplemented Neuro-
basal medium. Cortical and striatal neurons were isolated from E17.5
embryos as described (Raoul et al. 2002; Zala et al. 2005). Cortical
and striatal neurons were plated on poly-ornithine/laminin-treated
wells and cultured in Neurobasal medium complemented with 1 mM
sodium pyruvate, 2% B27 supplement (Invitrogen). Housing and
care of mice were performed in compliance with the European
Community and National directives for the care and use of laboratory
animals. Cos-7 and NSC34 cells were maintained in Dulbecco
Modiﬁed Eagle Medium (Invitrogen) supplemented with 10% fetal
bovine serum.
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For infection of primary neurons, 1 day after plating, half of the
culture media was removed and replaced with fresh supplemented
media containing AAV particles. Cells were then incubated for 5 h
at 37C, washed and fed again with corresponding supplemented
medium.
For survival assays we used the following reagents: tunicamycin,
caffeine, dantrolene, 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo (F)
quinoxaline (NBQX) and MDL-28170 were from Sigma (St Louis,
MO, USA). Thapsigargin and z-Asp(OMe)-Glu(OMe)-Val-As-
p(OMe)-fmk were from Calbiochem (San Diego, CA, USA).
Salubrinal and 1,2-bis(2-Aminophenoxy)ethane-N,N,N¢,N¢-tetraace-
tic acid tetrakis(acetoxymethyl) ester (BAPTA/AM)were fromAlexis
Corporation (San Diego, CA, USA). z-Ala-Thr-Ala-Asp(OME)-fmk
(z-ATAD-fmk) was purchased from MBL international corporation
(Woburn, MA, USA).
VAPB antibodies and Western blotting
Rabbit polyclonal antibodies for human VAPB (DIM-705) were
raised using hVAPB peptide TVQSNSPISALAPTG conjugated to
keyhole-limpet hemocyanin. Antisera were puriﬁed on peptide-
sepharose afﬁnity column (P.A.R.I.S, Compie`gne, France).
Proteins were extracted using lysis buffer (50 mM Tris-HCl pH
7.5, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA and 1% sodium
dodecyl sulfate) supplemented with a protease inhibitor cocktail
(Roche Molecular Biochemicals, Indianapolis, IN, USA). Protein
concentration was determined using BCA kit (Pierce, Rockford, IL,
USA). Protein samples were separated by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis and blotted to nitrocellulose
membranes (Schleicher and Schuell, Whatman International Ltd,
Springﬁeld Mill, UK). All membrane blocking steps and antibody
dilutions were performed with 6% non-fat dry milk in phosphate-
buffered saline (PBS) containing 0.1% Tween-20, and washing steps
performed with PBS containing 0.1% Tween-20. The following
antibodies were used: anti-hVAPB (DIM-705, 1 : 4000), anti-VAPA
(sc-48698, Santa Cruz Biotechnology, Santa Cruz, CA, USA; 1 :
1000), anti-EGFP (TP401, Torrey Pines Biolabs (East Orange, NJ,
USA); 1 : 5000), anti-phospho inositol-requiring enzyme 1 (IRE1)
(ab48187, Abcam (Cambridge, MA, USA); 1 : 200), anti-actin (AC-
40; Sigma-Aldrich; 1 : 20 000). Proteins were then detected using
horseradish peroxidase-conjugated secondary antibodies and visual-
ized with the chemiluminescent horseradish peroxidase substrate
(Millipore Corporation, Bedford, MA, USA).
Immunocytochemistry
Cells were cultured onto poly-ornithine/laminin-treated glass cov-
erslips at a density of 5000 cells per cm2 and at indicated times ﬁxed
in 3.7% formaldehyde for 20 min at 20C. Cells were washed thrice
with PBS and then blocked for 1 h in PBS, 0.1% Triton X-100,
4% bovine serum albumin and 5% heat-inactivated donkey serum.
Coverslips were then incubated overnight at +4ºC with the
appropriate antibody: anti-hVAPB (DIM-705; 1 : 500), anti-KDEL
(Lys-Asp-Glu-Leu) (SPA-827, Stressgen, Collegeville, PA, USA; 1 :
500), anti-non-phosphorylated neuroﬁlament (Covance, Princeton,
NJ, USA); 1 : 500), anti-b-COP (M3A5, Sigma-Aldrich; 1 : 300),
anti-GM130 (612008, BD Biosciences; 1 : 300), anti-cytochrome c
(6H2.B4, BD Biosciences, Franklin Lakes, NJ, USA; 1 : 500), anti-
phospho-IRE1 (ab48187, Abcam; 1 : 200), anti-cleaved caspase 3
(9661, Cell Signaling Technology, Beverly, MA, USA; 1 : 200),
anti-caspase 12 (14F7, Sigma-Aldrich; 1 : 500). Cells were washed
four times for 5 min each with PBS, incubated with the appropriate
ﬂuorescent-conjugated secondary antibody (Invitrogen), washed,
and mounted in moviol.
For quantiﬁcation of IRE1 phosphorylation, Hb9::GFP motoneu-
rons were infected by indicated AAV and immunostained with
anti-phospho-IRE1 antibodies as described above. Images of
phospho-IRE1 immunostaining were collected with an Olympus
(Tokyo, Japan) BX50WI confocal laser-scanning microscope using a
20· (UplanApo, N.A 0.70) objective. Fluorescence analysis was
performed using Metamorph software (Universal Imaging Corpora-
tion, Downingtown, PA, USA) on Hb9::GFPmotoneurons that were
automatically selected on GFP native ﬂuorescence. Analysis of mean
ﬂuorescence intensity was performed on 130-320 motoneurons per
culture condition.
Calcium imaging
To monitor quantitative changes of [Ca2+]i in Hb9::GFP motoneu-
rons we used a Fura-Red acetoxymethyl ester (AM) dye (Invitrogen)
whose emission spectra (630–700 nm) does not overlap with
emission of GFP (500–600 nm) and thus allows effective ratiometric
ﬂuorescence measurement without any GFP emitted ﬂuorescence
contamination. Other ratiometric Ca2+-sensitive dyes Indo-1 and
fura-2 possess common with GFP emission spectra, partially overlap
with GFP excitation spectra that introduces an additional mistake
during quantitative ratiometric [Ca2+]I measurements. For dye
loading, coverlips were rinsed with an external solution containing
150 mM NaCl, 2 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 10 mM
HEPES, 10 mM glucose, pH 7.4 and incubated in the same solution
containing 20 lM Fura-Red AM for 30 min in the dark at 20C, the
dye was washed off and the coverslips reincubated in the dark for a
further 60 min at 20C to allow de-esteriﬁcation of the dye. After
loading, coverslips were transferred to the stage of an NIKON
Diaphot 300 microscope (20· or 40· long distance lens). To
selectively visualize Ca2+in motoneurons we ﬁrst focused on GFP
ﬂuorescent cells using appropriate ﬁlter setting [excitation 480 (40)
nm, emission 535 (50) nm] and thereafter acquired ﬂuorescent
images of Fura-Red. Fura-Red was alternately excited at 440 (10)
nm and 490 (10) nm using a xenon light source (Sutter Instruments,
Novato, CA, USA), and emission collected at 660 (50) nm using a
CCD camera (Hamamatsu, Bridgewater, NJ, USA). All ﬁlters were
bandpass with bandwidths indicated in parentheses (Chroma
Technology corp., Bellows Falls, VT, USA). Images were acquired
at 2 s intervals and analyzed ofﬂine with SimplePCI software
(Hamamatsu). For [Ca2+]I analysis we ﬁrst draw regions of interest
on motoneurons (GFP positive cells) and then applied these regions
of interest for analysis of Fura-Red images. [Ca2+]i values were
presented as the 490/440 nm ratio. During experiments, neurons
were continuously perfused with external solution. Twenty seconds
after beginning the experiment neurons were activated by a brief (10
s) application of the solution containing 50 mM KCl (KCl replaced
equimolar amount of NaCl in external solution and was applied via
fast perfusion system).
Statistical analyses
Statistical analyses were performed by unpaired two-tailed t test or
by a one-way analysis of variance (ANOVA) followed by a Student-
Newman–Keuls’s post hoc test using the GraphPad Instat software
(GraphPad Software, La Jolla, CA, USA). Signiﬁcance was
accepted at the level of p < 0.05.
 2010 The Authors
Journal Compilation  2010 International Society for Neurochemistry, J. Neurochem. (2010) 114, 795–809
VAPB-mediated selective of motoneurons | 797
Results
AAV-mediated expression of hVAPBP56S leads to the
formation of cytoplasmic aggregates in embryonic
motoneurons
To investigate the functional consequences of the expression
of the ALS-linked human VAPBP56S mutant (hVAPBP56S) in
motoneurons, we developed an in vitromodel based on AAV-
mediated gene transfer. Using a recombinant AAV serotype 6
driving expression of the enhanced green ﬂuorescent protein
(AAV-EGFP) (Fig. 1a), we showed that AAV provide a simple
and efﬁcient means of stable gene expression in the motoneu-
ron culture system. Indeed, at the multiplicity of infection
(m.o.i) of 10 TU per cell (3 · 104 TU/mL), AAV serotype 6
can transduce up to 90% of motoneurons, with an early and
sustained transgene expression (detectable from 6 h to
15 days post-infection) and limited toxicity (Appendix S1).
Adeno-associated viral constructs were then engineered to
achieve expression of human VAPB wild-type (AAV-
hVAPBWT), VAPB mutant (AAV-hVAPBP56S) or hVAPA
(AAV-hVAPA), a member of the VAP family, which has not
been linked to motoneuron disease. To facilitate the detection
of hVAPBs, we generated polyclonal antibodies that specif-
ically recognize human VAPB, both in western blot and
immunocytochemistry (Figure S1a–d). We conﬁrmed by
western blot the ability of AAV-hVAPBWT, AAV-hVAPBP56S
and hVAPA viral vectors to drive expression of their
corresponding transgene (Fig. 1b). In accordance with previ-
ous reports (Kanekura et al. 2006; Suzuki et al. 2009), we
observed that steady-state levels of hVAPBP56S were lower
than that of hVAPBWT, even though cells were infected with
the same m.o.i. We next evaluated the cellular distribution of
hVAPBWT, hVAPBP56S and hVAPA in motoneurons.
Although, we showed functional AAV-mediated VAPA
expression by western blot (Fig. 1b), we were not able, with
the available antibodies, to speciﬁcally detect the human form
ofVAPAby immunoﬂuorescence inmotoneurons.We showed
that hVAPBWT co-localizes with KDEL, an ER marker and
with b-COP a component of coat protein complex I vesicles in
motoneurons (Fig. 1c–f).Whereas, AAV-mediated expression
of hVAPBP56S leads to the formation of cytoplasmic aggre-
gates that frequently co-localizedwithKDEL and occasionally
with b-COP (Fig. 1c–f), we did not observe any co-localiza-
tion of hVAPBP56S aggregates with the Golgi matrix protein
GM130 or the mitochondrial marker, cytochrome c (Fig-
ure S2a and d). AAV are thus effective gene expression
platforms to study the impact of hVAPB wild-type and mutant
over-expression on motoneuron functional integrity.
Over-expression of hVAPBWT and hVAPBP56S selectively
triggers death of motoneurons
We examined the consequence of the over-expression of
VAP family members on motoneuron survival. After 24 h in
culture, motoneurons were infected at the same m.o.i with
AAV-hVAPBWT, AAV-hVAPBP56S, AAV-hVAPA or AAV-
EGFP. According to the high-efﬁciency transduction of
motoneurons by AAV, we directly counted, at the time
indicated, the number of phase-bright neurons using mor-
phological criteria as previously described (Raoul et al.
2002). Regardless of the inherent toxicity of viral vectors
(Appendix S1), the survival curves of motoneurons infected
with AAV-hVAPA or AAV-EGFP motoneuron did not
signiﬁcantly vary over the time and were indistinguishable
(Fig. 2a). In contrast, AAV-mediated expression of
hVAPBWT induced rapid death of motoneurons, half of them
dying by 1 day post-infection (DPI). Expression of
hVAPBWT for a longer period (4 DPI) did not result in any
further increase in cell death, even though expression of
hVAPBWT continued in the surviving motoneurons (not
shown). Interestingly, we observed that motoneurons in-
fected with the disease-associated hVAPBP56S died more
slowly than neurons infected with wild-type hVAPB
(Fig. 2a). It is noteworthy that the susceptibility of moto-
neurons to hVAPBP56S may not necessarily correlate with the
presence of cytoplasmic inclusions. Indeed, at 2, 3 or 4 DPI,
the surviving motoneurons showed an accumulation of
hVAPBP56S into cytoplasmic aggregates (Fig. 1c–f and not
shown).
To establish whether the vulnerability of motoneurons to
hVAPBs over-expression might be relevant to pathogenesis
of motoneuron disease, we determined the susceptibility of
other neuronal types to hVAPBWT or hVAPBP56S over-
expression. We ﬁrst evaluated the efﬁcacy of AAV6 to drive
transgene expression in embryonic cortical and striatal
neurons. We showed that 92.1 ± 1.9% of cortical and
91.3 ± 2.1% of striatal neurons were transduced by AAV-
EGFP (mean ± SD, n = 3). The toxicity associated with
AAV vectors was 14.9 ± 1.8% for cortical neurons and
18.6 ± 5.2% for striatal neurons (mean ± SD, n = 3). When
both types of neurons were infected with AAV-hVAPBWT
and AAV-hVAPBP56S, we observed the expression of
hVAPBWT in the ER and the accumulation of hVAPBP56S
as cytoplasmic aggregates (Figure S3a and b). We then
analyzed the time-dependent survival of cortical and striatal
neurons infected with AAV-hVAPBWT, AAV-hVAPBP56S,
AAV-hVAPA or AAV-EGFP. Contrary to motoneurons, we
found that the survival of cortical and striatal neurons
infected with AAV-hVAPBWT and AAV-hVAPBP56S was
similar to the survival of those infected with AAV-hVAPA
and AAV-EGFP viral vectors (Fig. 2b and c). These ﬁndings
indicate that motoneurons are selectively vulnerable to
increased levels of both wild-type and mutant VAPB.
AAV-based expression of hVAPBWT and hVAPBP56S induces
ER stress in motoneurons
Three proximal sensors in mammalian cells trigger ER stress
response: the IRE1, the double-stranded RNA-activated
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Fig. 1 Human vesicle-associated membrane protein-associated pro-
tein B wild-type (hVAPBWT) mainly localizes at the ER, whereas
mutated hVAPB (hVAPBP56S) forms cytosolic aggregates in
Adeno-associated viral (AAV)-transduced motoneurons. (a) EGFP
fluorescence in motoneurons, as identified by non-phosphorylated
neurofilament (SMI32) immunostaining, 2 days following infection with
AAV-EGFP. AAV serotype 6 transduce up to 90% of motoneurons
in vitro. (b) Western Blot analysis of hVAPB, hVAPA and EGFP
expression in NSC34 cells 2 days post-infection (DPI). The actin was
used as a loading control. To study hVAPBWT and hVAPBP56S sub-
cellular localization, motoneurons were infected (or not) with AAV-
hVAPBWT or AAV-hVAPBP56S and processed for co-immunostaining
with anti-hVAPB and anti-KDEL (c, d) or anti-b-COP antibodies (e, f) 1
DPI for hVAPBWT and 3 DPI for hVAPBP56S [the time at which VAPB
mutant aggregate become obvious]. (d) and (f) represent higher
magnification images of motoneurons infected with AAV-hVAPBWT
and AAV-hVAPBP56S, co-immunostained with hVAPB and KDEL (d) or
b-COP (f). Scale bar in (c) and (e), 20 lm; (d) and (f), 2 lm.
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protein kinase-like ER kinase1 and the protein activating
transcription factor 6 (ATF6). VAPB has been proposed to
act in the ER stress response. Nevertheless, how VAPB
contributes to the homeostatic response of ER to stress
remains unclear. Indeed, over-expression of VAPB wild-type
but not VAPB mutant, triggered activation of the IRE1
downstream effector, X-box binding protein (XBP1) in
NSC34 cell line (Kanekura et al. 2006; Suzuki et al. 2009).
In another study, over-expression of both wild-type and
mutant VAPB attenuated ATF6/XBP1-dependent transcrip-
tion in HEK293 and NSC34 cells (Gkogkas et al. 2008). We
therefore explored whether ER stress might contribute to the
vulnerability of primary motoneurons to hVAPBs over-
expression. Toward this goal, we determined by quantitative
confocal microscopy the phosphorylation status of IRE1 in
motoneurons. To identify motoneurons in an automated
manner, we isolated them from Hb9::GFP mice in which, the
motoneuron-selective Hb9 promoter drives expression of the
GFP (Wichterle et al. 2002). After validating the speciﬁcity
of phospho-IRE1 immunoreactivity (Figure S4), we revealed
that the ER stress inducer thapsigargin, induced an IRE1-
dependent ER stress response in Hb9::GFP motoneurons
(Fig. 3a and b). As activation of IRE1 is an early key event in
ER stress, we analyzed the phosphorylation levels of IRE1
6 h post-infection. As mentioned above, at this early time
point, any native EGFP, that might interfere in the automated
identiﬁcation of Hb9::GFP motoneurons was not observed
in normal neurons infected with AAV-EGFP. When
motoneurons were infected both with AAV-hVAPBWT and
AAV-hVAPBP56S, we found a signiﬁcant increase in the
immunoﬂuorescence intensities of phosphorylated IRE1
(Fig. 3b). In contrast, the mean phospho-IRE1 immunoﬂu-
orescence of motoneurons infected with AAV-EGFP did not
differ from that of non-infected cells (Fig. 3b).
Salubrinal can act as a neuroprotective agent through
inhibition of ER stress (Saxena et al. 2009). When added to
culture media, we found that salubrinal saved motoneurons
from death induced by over-expression of both hVAPBWT
and hVAPBP56S (Fig. 3c). We conﬁrmed by counting the
percentage of EGFP-positive motoneurons 4 DPI that
salubrinal, at this concentration, did not lead to unspeciﬁc
transcriptional or translational repression of the viral con-
struct (AAV-EGFP-infected motoneurons, 100 ± 6.8%;
AAV-EGFP-infected motoneurons treated with salubrinal,
94.1 ± 2.4% EGFP positive neurons at 4 DPI, mean ± SD,
n = 3). These results suggest that ER stress is involved in
death of motoneurons induced by over-expression of
hVAPBWT and hVAPBP56S.
Motoneurons are more vulnerable than other neurons to an
increase in intracellular Ca2+ levels
We next explored whether the ER stress pathway underlies
the selective vulnerability of motoneurons to AAV-mediated
over-expression of hVAPBWT and hVAPBP56S. Motoneu-
rons, cortical and striatal neurons were thus challenged with
increasing concentrations of the ER stress inducer tunica-
mycin, an inhibitor of N-glycosylation. Tunicamycin induces
death of motoneurons, cortical and striatal neurons in a dose-
dependent manner, and the dose response curve of moto-
neurons to tunicamycin did not signiﬁcantly differ from that
of cortical or striatal neurons (Fig. 4a). To conﬁrm this
result, we used thapsigargin, which induces ER stress by
Fig. 2 Adeno-associated viral (AAV)-mediated expression of human
vesicle-associated membrane protein-associated protein B wild-type
(hVAPBWT) and hVAPBP56S selectively induces death of motoneu-
rons. Motoneurons (a), cortical (b) and striatal (c) neurons were pla-
ted at the density of 1500 cells per cm2, cultured for 1 day and
infected with indicated AAV vectors at the multiplicity of infection of 10
transducing units per cell. The number of surviving neurons was
determined at indicated times by counting cells under phase-contrast
microscope. Neuron survival was expressed as a percentage of the
number of surviving neurons in non-infected conditions for each day.
Data represent the mean values ± SD of three independent experi-
ments, each performed in triplicate or quadruplicate (ANOVA with
Student-Newman–Keuls’s post hoc test, ***p < 0.001).
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disrupting intralumenal Ca2+ homeostasis through a selective
inhibition of the sarco/endoplasmic reticulum Ca2+ ATPase.
Interestingly, we observed that motoneurons show an
increased susceptibility to thapsigargin-induced ER stress
compared to cortical and striatal neurons (Fig. 4b). This
suggests that motoneurons might have an exacerbated
susceptibility to aberrant Ca2+ signals rather than to ER
stress. With this in mind, we cultured motoneurons, cortical
and striatal neurons in the presence of increasing concen-
trations of caffeine, an agonist of ryanodine receptors (RyRs)
driving release of Ca2+ from the ER. Caffeine does not
signiﬁcantly affect survival of cortical and striatal neurons,
whereas under the same conditions, caffeine induces death
of about 50% of motoneurons in a dose-dependent manner
(Fig. 4c). Overall our ﬁndings suggest that despite the
involvement of the ER stress response in the death of
motoneurons induced by hVAPBWT and hVAPBP56S over-
expression, an altered Ca2+ homeostasis might underlie their
selective vulnerability.
AAV-mediated over-expression of wild-type and mutant
human VAPB impairs Ca2+ homeostasis in motoneurons
To investigate whether the over-expression of hVAPBWT or
hVAPBP56S has an impact on the capacity of Ca2+ regulation
in motoneurons, we examined through ratiometric Ca2+
imaging their responses to a high potassium (K+) stimulus.
Indeed, high K+ depolarization evokes a Ca2+ inﬂux, whose
amplitude depends on the homeostatic regulation of intra-
cellular Ca2+ [(Ca2+)i](Gou-Fabregas et al. 2009). To facil-
itate the analysis of Ca2+ transients in motoneurons, we
isolated them from Hb9::GFP transgenic mice. Simultaneous
dual-color imaging of GFP and the Ca2+-sensitive dyes Fura-
Red was performed 6 h post-infection to study early events
taking place well before the resulting cell death (Fig. 5a). At
this time point, we were not able to detect any native EGFP
ﬂuorescence in AAV-EGFP-infected motoneurons that might
interfere in the identiﬁcation of Hb9::GFP motoneurons. We
ﬁrst showed that motoneurons, infected or not, respond to
membrane depolarization by a Ca2+ inﬂux that leads to an
increased [Ca2+]i (Fig. 5a–c). It is noteworthy that a trend
(non-signiﬁcant) towards greater basal Ca2+ levels in moto-
neurons was seen following transduction with hVAPBWT and
hVAPBP56S compared to EGFP (Fig. 5d). When we deter-
mined the amplitude of the Ca2+ response to high K+
concentrations, we found that AAV-mediated expression of
both hVAPBWT and hVAPBP56S led to a signiﬁcant reduction
in the amplitude of Ca2+ transients (Fig. 5e). This suggests
that death of motoneurons, induced by over-expression of
Fig. 3 Adeno-associated viral (AAV) 6-mediated over-expression of
human vesicle-associated membrane protein-associated protein B
wild-type (hVAPBWT) and hVAPBP56S induces ER stress activation in
motoneurons. (a, b) Expression of both hVAPBWT and hVAPBP56S
leads to increased levels of phosphorylated inositol-requiring enzyme
1 (IRE1) in motoneurons. (a) Immunodetection of phosphorylated
IRE1 in motoneurons isolated from Hb9::GFP transgenic mice 6 h
following infection with indicated viral vectors. Scale bar, 20 lm. (b)
Quantification of phospho-IRE1 fluorescence in Hb9::GFP moto-
neurons infected (or not) with AAV-EGFP, AAV-hVAPBWT or AAV-
hVAPBP56S. Confocal fluorescence imaging and Metamorph image
analysis were used to determine mean fluorescence intensity in indi-
cated conditions (a.u, arbitrary unit). (c) Salubrinal saves motoneurons
from hVAPB-induced death. Motoneurons were infected with indicated
viral vectors and cultured in the presence or absence of salubrinal
(5 lM). Survival was determined at 4 day post-infection. Motoneuron
survival was expressed relative to non-infected neurons in the pres-
ence or not of salubrinal. Results shown in (b) and (c) are the mean
values ± SD of three independent experiments performed in triplicates
(ANOVA with Student-Newman–Keuls’s post hoc test, ***p < 0.001; n.s,
non-significant).
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wild-type and mutant hVAPB, might rely on changes in the
intracellular calcium homeostasis.
Ca2+ signals are required to trigger death of motoneurons
following over-expression of wild-type and mutant hVAPB
We next aimed at investigating the functional contribution of
Ca2+ in motoneuron death induced by over-expression of
hVAPBWT or hVAPBP56S. We ﬁrst examined the effect of the
reduction of [Ca2+]i on motoneuron survival by using the
membrane permeable Ca2+ chelator BAPTA/AM. We found
that BAPTA/AM prevented motoneuron death following
infection with AAV-hVAPBWT and hVAPBP56S (Fig. 6a and
Figure S5a), arguing for a role of Ca2+ signals in the death
process.
The selective sensitivity of motoneurons to an elevation of
[Ca2+]i through activation of RyRs (Fig. 4c) paralleled the
disturbed Ca2+ homeostasis associated with hVAPBWT and
hVAPBP56S over-expression (Fig. 5e), suggests that Ca2+
signals from the ER store may intervene in the death
pathway. We then evaluated the neuroprotective effect of
dantrolene, a selective inhibitor of RyRs that antagonizes
Ca2+-induced Ca2+ release (CICR), on hVAPB-induced
death. We ﬁrst ensured that dantrolene did not unspeciﬁcally
inﬂuence viral-mediated gene expression in motoneurons
(AAV-EGFP, 100 ± 2.4%; AAV-EGFP with dantrolene, 94 ±
6.8% EGFP positive motoneurons at 4 DPI, mean ± SD,
n = 3). We then showed that dantrolene signiﬁcantly saved
motoneurons from AAV-mediated over-expression of
hVAPBWT and hVAPBP56S (Fig. 6b and Figure S5b), sug-
gesting that activation of CICR via RyRs participates in
Ca2+-dependent death signaling in motoneurons.
Ca2+-induced Ca2+ release has been demonstrated to
participate in the generation of Ca2+ transients elicited by a-
amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/
Kainate (KA)-type glutamate receptors during spontane-
ously occurring excitatory post-synaptic currents in cultured
motoneurons (Jahn et al. 2006). Thus, we hypothesized that
the impaired homeostatic regulation of Ca2+ induced by
hVAPBWT and hVAPBP56S would impact on survival
through an aberrant response to AMPA/KA-mediated Ca2+
inﬂuxes evoked by spontaneous inward currents. To address
this question, we determined whether the AMPA/KA
antagonist, NBQX, protected motoneurons from hVAPBWT
and hVAPBP56S over-expression. As predicted, exposing
motoneurons infected with AAV-hVAPBWT and AAV-
hVAPBP56S to NBQX, signiﬁcantly rescues them from the
degenerative process (Fig. 6c and Figure S5c). We checked
that NBQX did not lead to an unspeciﬁc repression of viral-
mediated gene expression (AAV-EGFP, 100 ± 7.9%; AAV-
EGFP in the presence of NBQX, 93.6 ± 8.1% EGFP
positive motoneurons at 4 DPI, mean ± SD, n = 3).
Collectively, our results suggest that defective Ca2+ signal-
ing contributes to the death of motoneurons induced by the
over-expression of hVAPBWT and hVAPBP56S.
Fig. 4 Motoneurons show an increased susceptibility to calcium re-
lease from the ER. Motoneurons, cortical and striatal neurons were
cultured for 1 day, treated with indicated concentrations of thapsigar-
gin (a), caffeine (b) and tunycamycin (c) and survival determined by
direct counting 1 day after. Neuron survival was expressed relative to
the number of cells surviving in the non-treated condition. Data rep-
resent the mean values ± SD of three independent experiments
(ANOVA with Student-Newman–Keuls’s post hoc test, **p < 0.01,
***p < 0.001).
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An ER-associated pathway is involved in death of
motoneurons triggered by both hVAPBWT and hVAPBP56S
Which Ca2+-dependent ER-related death executioners par-
ticipate in motoneuron death following AAV-promoted
over-expression of hVAPBWT and hVAPBP56S? The role of
Ca2+-activated cystein proteases, calpains, in neuronal death
in response to Ca2+ signals has been well documented
(Raynaud and Marcilhac 2006). To explore the functional
Fig. 5 Adeno-associated viral (AAV) 6-mediated over-expression of
human vesicle-associated membrane protein-associated protein B
wild-type (hVAPBWT) and hVAPBP56S disturbs calcium homeostasis
in motoneurons. (a) Ratiometric [Ca2+]i measurement in motoneu-
rons. Top row represents an example of GFP and Fura-Red fluo-
rescences in the same Hb9::GFP motoneurons (taken using
mentioned filter sets, see materials and methods). The equal inten-
sity of Fura-Red fluorescence in both GFP positive and GFP nega-
tive cells (top right image) highlights the absence of overlap between
GFP and Fura-Red fluorescence signals. Bottom row represents
Fura-Red fluorescence (excitation 490 nm) in neurons before, during
and after bath application of 100 mM KCl. (b) [Ca2+]i quantification in
one of the motoneurons visualized in (a). Fura-Red fluorescence
change when excited using 440 nm and 490 nm filters in response to
KCl application. (c) Ratio of fluorescence intensities illustrated in (b).
Basal level of [Ca2+]i (d) and amplitudes of neuronal response to
application of KCl (e) in motoneurons infected by indicated AAV.
Data from five experiments, 10–20 neurons per experiment. Data
shown in (d) are in box-and-whisker plot format and data in (e) are
means ± SEM.
 2010 The Authors
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involvement of calpains in hVAPB-induced death, we used
the potent inhibitor of the ubiquitously expressed l- and
m-calpain, MDL-28170 in our in vitro paradigm. We
conﬁrmed that at the indicated concentration MDL-28170
did not repress AAV-promoted transgene expression (AAV-
EGFP, 100 ± 3%; AAV-EGFP in the presence of MDL-
28170, 99.7 ± 5.1% EGFP positive motoneurons at 4 DPI,
mean ± SD, n = 3). We subsequently found that treatment
with MDL-28170 rescued AAV-hVAPBWT- and AAV-
hVAPBP56S-infected motoneurons from death (Fig. 7a and
Figure S5d).
Caspase 12 is an ER resident caspase that plays an
important role during ER stress-induced apoptosis. In addi-
tion, caspase 12 can be proteolytically activated by calpains
following an elevation of intracellular Ca2+ (Tan et al. 2006).
We found that caspase 12 mainly co-localized with hVAPBWT
at the ER but barely co-localized with hVAPB mutant
cytoplasmic aggregates in motoneurons (Figure S6a). When
we irreversibly inhibited caspase 12 through the synthetic
peptide z-ATAD-fmk, we saved motoneurons from death
induced by over-expression of hVAPBWT and hVAPBP56S
(Fig. 7b and Figure S6b). We also ensured that z-ATAD-fmk
did not inﬂuence AAV-mediated transgene expression by
determining the percentage of motoneurons showing EGFP
ﬂuorescence 4 DPI (AAV-EGFP, 100 ± 4.3%; AAV-EGFP in
the presence of z-ATAD-fmk, 96.8 ± 6.1%, mean ± SD,
n = 3). Our data suggests that caspase 12, in spite of its
different co-localization with wild-type and mutant VAPB, is
a common effector of the motoneuron death process.
Caspase 3 is the primary executioner caspase of the
calpain-/caspase 12-dependent death pathway. To investigate
whether caspase 3 contributed to hVAPB wild-type and
mutant-induced death of motoneurons, we ﬁrst probed
motoneurons infected (or not) with AAV-EGFP, AAV-
hVAPBWT and hVAPBP56S with antibodies speciﬁc to the
cleaved form of caspase 3. Consistent with the kinetics of
death promoted by hVAPBWT and hVAPBP56S over-expres-
sion, the percentage of motoneurons showing an activation of
caspase 3 associated with a nuclear pyknosis increased more
rapidly when neurons were transduced with hVAPBWT (16 h
post-infection), and more slowly when neurons were trans-
duced with hVAPBP56S (3 days post-infection) (Fig. 7c–e).
To conﬁrm the involvement of caspase 3 in the degenerative
process in vitro, we employed the caspase 3/7 caspase
inhibitor z-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fmk, which
saved motoneurons from death induced by hVAPBWT and
hVAPBP56S over-expression (Fig. 7f and Figure S6c). All
together, these results suggest that the death of motoneurons
triggered by AAV-mediated over-expression of wild-type and
mutant hVAPB implicates Ca2+ -sensitive calpains and an
ER-associated caspase cascade.
Discussion
The results presented in this study are consistent with a
causative role of P56S mutant VAPB in motoneuron degen-
eration (Nishimura et al. 2004, 2005). Here, we show that
viral delivery of VAPB mutant selectively triggers death of
cultured motoneurons. To our surprise, AAV-mediated over-
expression of the wild-type form of VAPB, but not VAPA,
also induces a selective death of motoneurons, with an even
more rapid kinetics of death. The expression of hVAPBWT
Fig. 6 Calcium signals are required for human vesicle-associated
membrane protein-associated protein B (hVAPB)-induced death.
Motoneurons were infected or not with Adeno-associated viral (AAV)-
EGFP, AAV-hVAPBWT or AAV-hVAPBP56S 1 day after plating and
treated or not with the intracellular Ca2+ chelator 1,2-bis(2-Amino-
phenoxy)ethane-N,N,N’,N’-tetraacetic acid tetrakis(acetoxymethyl)
ester (BAPTA/AM) (1 lg/mL) (a), the ryanodine receptors inhibitor
dantrolene (5 lM) (b) or the a-amino-3-hydroxy-5-methylisoxazole-4-
propionate/Kainate antagonist NBQX (10 lM) (c). Motoneuron sur-
vival was determined 4 day post-infection. All values are expressed as
the mean ± SD of three independent experiments, each performed in
triplicate (ANOVA with Student-Newman–Keuls’s post hoc test,
*p < 0.05 and ***p < 0.001).
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Fig. 7 Adeno-associated viral (AAV) 6-mediated over-expression of
human vesicle-associated membrane protein-associated protein B
wild-type (hVAPBWT) and hVAPBP56S triggers motoneuron death in a
calpain and caspase-dependant manner. (a, b) Calpain and caspase
12 inhibitors save motoneurons from vesicle-associated membrane
protein-associated protein B (VAPB)-induced death. Motoneurons
were infected or not with indicated viral vectors and incubated in the
presence or not of the calpain inhibitor MDL-28170 (5 lM) (a) or the
caspase 12 inhibitor z-Ala-Thr-Ala-Asp(OME)-fmk (z-ATAD-fmk)
(10 lM) (b). The number of surviving neurons in the presence or
absence of the indicated inhibitor was expressed as a percentage of
the number of non-infected surviving neurons 4 day post-infection.
(c–e) Caspase 3 activation is involved in hVAPBWT and hVAPP56S-
mediated death of motoneurons. Hb9::GFP motoneurons were in-
fected or not with AAV-hVAPBWT or AAV-VAPBP56S and immuno-
stained with antibodies directed against the cleaved form of caspase 3.
The nuclei were stained with DAPI. (d, e) The percentage of moto-
neurons positive for cleaved caspase 3 and showing a pyknotic nucleus
was determined 16 h (d) and 3 days (e) after the infection by indicated
AAV. (f) Motoneuron survival was assessed 4 day post-infection with
indicated AAV in the presence or not of the caspase 3 inhibitor z-As-
p(OMe)-Glu(OMe)-Val-Asp(OMe)-fmk (z-DEVD-fmk; 10 lM). Graphs
in (a), (b), (d), (e) and (f) show one representative of three independent
experiments, (values are means ± SD, n.s, non-significant).
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and hVAPBP56S leads to ER stress, which contributes to the
death process. However, the selective susceptibility of
motoneurons to VAPBs over-expression compared to cortical
and striatal neurons is most likely explained by an altered
homeostatic regulation of Ca2+ signals. The implication of
calpains, caspase 12 and caspase 3 completes this ER-
associated Ca2+-dependent death pathway induced by over-
expression of both wild-type and mutant hVAPB.
The unfolded protein response (UPR) facilitates folding,
processing, export, and degradation of proteins originating
from the ER under stress conditions. When the stressful
insult is too over-whelming, or when UPR is chronically
activated, cells undergo apoptosis through a speciﬁc ER
stress response (Schroder and Kaufman 2005). Recently,
longitudinal gene expression proﬁling of ALS-vulnerable
and ALS-resistant motoneurons in different SOD1 mutant
models documented the critical role of ER stress in the
selective susceptibility of motoneurons in the disease (Sax-
ena et al. 2009). The accumulation of evidence that ER stress
might also contribute to sporadic ALS, has highlighted the
ER stress as an important physiopathologic mechanism in
ALS (Ilieva et al. 2007; Atkin et al. 2008; Ito et al. 2009).
Previous studies on the physiological involvement of VAPB
in UPR and ER stress resulted in conﬂicting data as to
whether VAPBWT can induce or reduce the UPR. However,
the P56S mutation that leads to the formation of aggregates
and recruitment of the wild-type protein into these aggregates
is most likely associated with a reduction of the activity of
UPR in cell lines (Kanekura et al. 2006; Gkogkas et al.
2008; Suzuki et al. 2009). The negative impact of mutant
VAPB on UPR activity may bring into play either a dominant
negative effect that would block the VAPB-mediated activa-
tion of IRE1/XBP1 pathway (Kanekura et al. 2006; Suzuki
et al. 2009) or potentiate the inhibitory activity of VAPB
wild-type on ATF6 activation (Gkogkas et al. 2008). Here,
we demonstrated that AAV delivery of both wild-type and
mutated forms of VAPB led to activation of IRE1 (Fig. 3b)
and that salubrinal, an ER-stress inhibitor that acts by
preventing dephosphorylation of eukaryotic translation ini-
tiation factor-2 subunit-alpha, confered a neuroprotective
effect (Boyce et al. 2005) (Fig. 3c). In addition, the speciﬁc
inhibition of caspase 12, a representative caspase involved in
ER stress, saved motoneurons from VAPBs over-expression
(Fig. 7b and Figure S6b). Several factors may account for
the discrepancies between our observations and those made
by other studies. Firstly, viral gene transfer achieved a
moderate gene expression level that may establish more
physiological levels of expression. Secondly, we used non-
tagged forms of VAPB proteins and it has been found that the
nature and position of the tag sequence can inﬂuence the
biochemical properties of the proteins (Suzuki et al. 2009).
Perhaps more importantly, the use of primary motoneurons,
displaying some intrinsic features of this neural cell type,
may reveal more relevant pathogenic mechanisms.
It is striking that a proportion of motoneurons appeared
intrinsically resistant to the over-expression both hVAPBWT
and hVAPBP56S (Fig. 2a). This differential vulnerability of
motoneurons to hVAPBs over-expression may reﬂect the
diversity of intrinsic properties of motoneurons. Indeed, a
variegation of intrinsic features has been proposed to
underlie the selective vulnerability of motoneuron subtypes
in the disease (Wetts and Vaughn 1996; Pun et al. 2006). In
ALS mice, both ALS-resistant and ALS-vulnerable moto-
neurons show an early increase in ubiquitin signals, which
might be regarded as a physiological response to mutant
SOD1 misfolding. However, an activation of ER stress
pathway selectively occurs in vulnerable subtypes (Saxena
et al. 2009). Whether the motoneuron population sensitive to
hVAPBs is the one that is more prone to ER stress response
remains to be elucidated.
What might account for the selective vulnerability of
motoneurons compared to other neuronal types? We
observed a selective susceptibility of motoneurons to ER-
stress induced by perturbed calcium homeostasis (Fig. 4b)
compared to ER stress induced by accumulation of unfolded
proteins (Fig. 4a), as well as a selective vulnerability of
motoneurons to elevated [Ca2+]i (Fig. 4c). This suggests that
Ca2+ signals might determine an ER stress-mediated selec-
tive death of motoneurons. Several studies in SOD1 mutant
FALS models propose that altered Ca2+ homeostasis under-
lies the selective vulnerability of motoneurons in ALS (von
Lewinski and Keller 2005; Ionov 2007). ALS-vulnerable
motoneurons in contrast to ALS-resistant and other neurons
are characterized by low cytosolic Ca2+ buffering capacities
(Vanselow and Keller 2000; von Lewinski et al. 2008). An
increased Ca2+ permeability of the AMPA/KA receptors
together with an impaired competence of Ca2+ clearance
exacerbates glutamate-mediated excitatory neurotransmis-
sion, which may contribute to motoneuron vulnerability in
ALS (Van Damme et al. 2005, 2007; Guatteo et al. 2007).
Data obtained from ratiometric analysis of Ca2+ transients
following membrane depolarization suggest that both wild-
type and mutant forms alter the homeostatic regulation of
Ca2+ (Fig. 5). Pharmacological inhibition of CICR, AMPA/
KA receptors or Ca2+ -dependent calpain proteases, rescued
hVAPBWT and hVAPBP56S-transduced motoneurons from
death (Fig. 6). Collectively our data argue for a crucial role
of Ca2+ signals in motoneuron vulnerability to hVAPB wild-
type or mutant over-expression, and further delineate Ca2+
signals as an important pathological signal in motoneuron
disease. Amplitude and duration of Ca2+ signals are deter-
mined by several interconnected mechanisms that control
Ca2+ inﬂux and extrusion through the plasma membrane as
well as Ca2+ sequestration or release from intracellular
stocks. How VAPB and its ALS-linked mutated form impact
on this highly dynamic system remains to be elucidated.
Viral delivery of neurodegenerative disease-associated
genes provides convenient models to investigate pathoge-
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netic mechanisms in vitro. Cell-autonomous and non-
cell-autonomous feature of motoneuron vulnerability in
motoneuron disease has been investigated using primary or
embryonic stem cell-derived culture of wild-type or SOD1
mutant motoneurons. For example, the selective vulnerability
of motoneurons to AMPA-mediated excitotoxicity associated
with GluR2 deﬁciency (Van Damme et al. 2007), the
exacerbated susceptibility of motoneurons puriﬁed from
SOD1 to the motoneuron-restricted Fas death pathway and
its effector, the Collapsin Response Mediator Protein 4a
(Raoul et al. 2002, 2006; Duplan et al. 2010), and the
motoneuron-selective neurotoxic effects of SOD1 mutant
damaged astrocytes (Pehar et al. 2004; Nagai et al. 2007).
Importantly, these culture systems complement genetic
in vivo models for studies of physiopathological mechanisms
and are instrumental in the development of therapeutic
strategies (Van Damme et al. 2005, 2007; Boillee et al.
2006; Locatelli et al. 2007; Yamanaka et al. 2008).
An important aspect of in vitro models relates to the
etiological mechanisms underlying neurodegenerative dis-
eases. Missense mutations in a-synuclein have been linked to
autosomal dominant forms of Parkinson’s disease. Experi-
mental modeling of Parkinson’s disease in vitro and in vivo
through viral-based gene transfer approaches showed that
over-expression of both the wild-type and mutant form of
a-synuclein led to the death of dopaminergic neurons (Lo
Bianco et al. 2002; Schneider et al. 2007). This suggests that
increased endogenous levels of the wild-type protein can
elicit neurotoxic effects in dopaminergic neurons in models.
Interestingly, gene dosage effects resulting from the dupli-
cation or triplication of the a-synuclein gene was found to
cause early-onset Parkinson’s disease (Eriksen et al. 2005).
Gene dosage effects were also reported in Alzheimer’s
disease, where the duplication of the amyloid precursor
protein gene has been linked to early-onset Alzheimer’s
disease (Rovelet-Lecrux et al. 2006), and in the Charcot-
Marie-Tooth type 1A motor sensory neuropathy, with
duplication of the peripheral myelin protein 22 gene
(Valentijn et al. 1992). Gene dosage effects, that have not
yet been reported to cause ALS, might plausibly be another
genetic factor in ALS.
Our data would indicate that the homeostatic function of
VAPB within the ER is of a considerable biological
signiﬁcance in motoneurons. Abnormal expression levels of
wild-type or expression of the mutated VAPB indeed led to
the disregulation of ER homeostasis and resulted in moto-
neuron degeneration. A loss-of-function characterized by the
aggregation of VAPB wild-type with or without other
proteins has been hypothesized as the causal mechanism of
ALS associated with P56S mutant VAPB (Kanekura et al.
2006; Teuling et al. 2007; Suzuki et al. 2009). The slower
death kinetics observed following over-expression of VAPB
mutant compared to wild-type VAPB could indeed result
from a gradual depletion and subsequent loss-of-function of
endogenous VAPBWT. Unfortunately, rescue experiments
consisting in the over-expression of wild-type protein in the
presence of mutant protein cannot be achieved in our in vitro
model. However, activation of the IRE1 signal and impaired
Ca2+ homeostasis are early events that occur concomitantly
following the forced expression of both VAPBWT and
hVAPBP56S. A plausible alternative hypothesis is that the
mutant protein acquired one or more toxic properties that
converge to the same effectors elicited when levels of the
wild-type protein are abnormal. Much is yet to be understood
about underlying mechanisms of the VAPB mutant protein in
the degeneration of motoneurons. Genetic models of VAPB,
including transgenic and VAPB-deﬁcient mice will therefore
be crucial for completing our understanding of motoneuron
biology. Our in vitromodel has helped us to identify potential
effector mechanisms, which have been demonstrated relevant
to other FALS models and therefore represent potential
therapeutic targets for motoneuron disease.
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of IRE1 speciﬁcally trace IRE1 activation following ER stress.
Figure S5. Short term protective effect of Ca2+ signaling
inhibition against hVAPBWT-induced death of motoneurons.
Figure S6. Inhibition of caspase 12 and 3 saves motoneurons
from hVAPBWT-induced death.
As a service to our authors and readers, this journal provides
supporting information supplied by the authors. Such materials are
peer-reviewed and may be re-organized for online delivery, but are
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not copy-edited or typeset. Technical support issues arising from
supporting information (other than missing ﬁles) should be
addressed to the authors.
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